MedAssets downgraded to Neutral from Buy at Citigroup Citigroup downgraded MedAssets to Neutral citing the recent loss of a major contract and continued weak utilization. Citi lowered its price target for shares to $26 from $28.
MedAssets expands relationship with Vanderbilt University Medical Center MedAssets announced Vanderbilt University Medical Center, or VUMC, has selected the company to provide Lean Healthcare Transformation & Integration Consulting services for operational process and performance improvement across its care continuum. The new 18-month engagement – largely focused on VUMC's clinical departments – will use innovative education, advanced problem-solving techniques and rapid improvement initiatives to guide VUMC staff in affecting and sustaining change. The agreement builds upon momentum created from Lean project engagements completed in 2014 as part of MedAssets longstanding relationship with VUMC.